On this page

Moyamoya occurs in children and adults. Recognizing the same vascular pattern does not make the evidence interchangeable. Age, associated conditions, previous events and the reason for considering treatment all belong in the discussion.1

Questions for caregivers

Children often come to attention through ischemic events, whereas adult presentations include both ischemia and hemorrhage. These are patterns described in guidance, not exclusions: an individual child's presentation still needs assessment. ESO's pediatric discussion emphasizes ongoing ischemic symptoms and hemodynamic impairment, with practical advice largely based on expert consensus.2

Ask who coordinates pediatric neurology, vascular surgery assessment and continuing care. Clarify how the team will respond to a further episode while treatment is being considered. Ask for a written, individual plan for school and caregivers rather than adapting adult advice or another family's restrictions.

The Riordan series provides a distinct pediatric perspective: patients treated at age 21 or younger by one team were followed over a long period. It is useful experience, but retrospective surgical follow-up cannot determine the best procedure for every child. Its definition of pediatric eligibility also includes young adults, which matters when comparing it with studies restricted to younger children.3

Questions for adult readers

Ask whether the main concern is ischemia, a previous hemorrhage or a finding without clinical events. The JAM trial belongs to the adult hemorrhagic question. It does not establish benefit for an adult who has never bled, much less for a child with ischemic symptoms.4

For an incidental diagnosis, ask how the team defines asymptomatic and whether imaging or blood-flow findings change that assessment. AMORE studied a selected adult group without episodes suggesting TIA or stroke. Its observational design cannot decide whether you should have preventive surgery.5

Why age-specific evidence matters

Direct and indirect operations are discussed in both age groups, but the feasibility and timing of new collateral circulation matter. ESO found no pediatric randomized comparison answering its technique question, and does not establish universal superiority. A surgeon's explanation should connect the proposed approach to the individual anatomy and clinical question, with the uncertainty made explicit.2

When shown a percentage, ask whether it counts children, adults, patients or operated hemispheres. Ask how many people were assessed at follow-up and whether a result measures strokes, disability or new vessels. A long observation period is valuable, but it does not eliminate selection bias or missing data.

Planning continuity of care

Caregiver questions can include learning and daily activities as well as recurrent events. Adults may want to discuss work, independence and longer-term care coordination. These are questions to raise, not predictions about a particular person's abilities.

For a young person moving between services, clarify who keeps the records, arranges surveillance and explains changes in the plan.

References

  1. US National Library of Medicine. MedlinePlus Genetics: Moyamoya disease. Webpage. Source ↩
  2. Bersano A et al. European Stroke Journal. 2023;8:55–84. doi:10.1177/23969873221144089. Corrected March 2023. Source ↩
  3. Riordan CP et al. Journal of Neurosurgery: Pediatrics. 2019;23:586–592. doi:10.3171/2019.1.PEDS18457. PubMed ↩
  4. Miyamoto S et al. Stroke. 2014;45:1415–1421. doi:10.1161/STROKEAHA.113.004386. PubMed ↩
  5. Kuroda S et al. Stroke. 2023;54:1494–1504. doi:10.1161/STROKEAHA.122.041932. PubMed ↩